Evidence map›Paper›PMID 34095053›Full record

ArticleFrontiers in public health2021

Impact of COVID-19 Pandemic on Pre-Treatment Delays, Detection, and Clinical Characteristics of Tuberculosis Patients in Ningxia Hui Autonomous Region, China.

Xiaolin Wang, Wencong He, Juan Lei, Guangtian Liu, Fei Huang, Yanlin Zhao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Xiaolin WangThe Fourth People's Hospital of Ning Xia Hui Autonomous Region, Yinchuan, China.
Wencong HeNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Juan LeiThe Fourth People's Hospital of Ning Xia Hui Autonomous Region, Yinchuan, China.
Guangtian LiuThe Fourth People's Hospital of Ning Xia Hui Autonomous Region, Yinchuan, China.
Fei HuangNational Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yanlin ZhaoNational Center for TB Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
The Fourth People's Hospital of Ningxia Hui Autonomous Region · CNChinese Center For Disease Control and Prevention · CNNational Institute for Communicable Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19TuberculosisChinaCommunicable Disease ControlHumansPandemicsSARS-CoV-2Time-to-TreatmentCOVID-19impactpre-treatment delayTB controltuberculosis

Identifiers

PMID34095053
PMCPMC8175850
OpenAlexW3162055324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.